BIOMARKERS

Molecular Biopsy of Human Tumors

Biomarkers for Cervical cancer

1. TP53
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
2. CDKN2A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
3. STIL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
4. BCL2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
5. ESR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
6. MYC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
7. PR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
8. GATA3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
9. ER
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
10. Ki-67
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
11. AR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
12. TG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
13. CEACAM5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
14. EGFR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
15. ERBB2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
16. AKT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
17. FBXW7
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
18. CCDC6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
19. MUC16
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
20. RB1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
21. PTCH1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
22. JUN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
23. MAPK1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
24. ROS1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
25. PIK3CA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
26. PPFIBP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
27. MS4A1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
28. FAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
29. APC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
30. CTLA4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
31. CD79A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
32. IL2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
33. HIF1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
34. TIMP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
35. NCKIPSD
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
36. ABL2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
37. MTOR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
38. TP63
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
39. KIT
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
40. FHIT
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
41. ITK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
42. PTEN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
43. hCG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
44. CALCB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
45. MDM2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
46. BRD4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
47. MUC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
48. NTRK1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
49. STAT3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
50. FGFR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
51. HRAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
52. SPEN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
53. MAX
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
54. GNAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
55. CDKN1B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
56. STK11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
57. ATM
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
58. HLA-A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
59. RET
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
60. FOXP3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
61. LDH
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
62. SRC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
63. PSA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
64. SERPINE1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
65. DDIT3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
66. FUS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
67. POU5F1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
68. MLH1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
69. SDHA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
70. TERT
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
71. FANCA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
72. BRCA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
73. CDK4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
74. KDR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
75. RHOA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
76. KRAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
77. CXCR4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
78. RARA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
79. BRAF
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
80. FH
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
81. PRKAR1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
82. BLM
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
83. NOTCH1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
84. uPA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
85. CALR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
86. AFP
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
87. SDHB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
88. ARID1B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
89. CCND1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
90. CDH1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
91. ABL1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
92. CDH11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
93. GOPC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
94. ELN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
95. PRF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
96. SMAD3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
97. SOX2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
98. BCR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
99. MSH2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
100. Beta-hCG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
101. ENO2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
102. HSP90AA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
103. EP300
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
104. FGFR2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
105. NRAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
106. CUX1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
107. CYLD
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
108. EZH2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
109. MYCN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
110. PTPRC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
111. PDCD1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
112. NKX2-1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
113. ABCG2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
114. CASP8
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
115. CHEK2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
116. CLIP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
117. FGFR3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
118. FLT4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
119. ATR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
120. BRCA2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
121. CREBBP
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
122. ERBB3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
123. PAX8
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
124. RAF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
125. SMAD4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
126. MYB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
127. POLE
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
128. PTPN11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
129. RAC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
130. RBM15
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
131. WT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
132. CDK6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
133. CDX2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
134. RHOH
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
135. MET
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
136. CD274
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
137. DNMT3A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
138. FOXO1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
139. MAP2K1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
140. SMAD2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
141. VHL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
142. DICER1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
143. HMGA2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
144. KMT2A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
145. TOP2A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
146. ALK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
147. CTNNB1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
148. MDM4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
149. NUTM1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
150. ERCC2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
151. MALAT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
152. MYOD1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
153. NFE2L2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
154. REL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
155. TRA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
156. CgA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
157. ARID1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
158. EZR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
159. JAK2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
160. MSH6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
161. MSN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
162. NDRG1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
163. NR4A3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
164. PDGFB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
165. RECQL4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
166. TSC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
167. YWHAE
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
168. APOBEC3B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
169. ETV6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
170. FES
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
171. NT5C2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
172. PML
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
173. SFRP4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
174. SMARCA4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
175. STAT5B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
176. TAL1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
177. TSC2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
178. BUB1B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
179. CIC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
180. DROSHA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
181. ERBB4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
182. LMNA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
183. NBN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
184. NF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
185. NF2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
186. PDGFRB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
187. PMS2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
188. SMO
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
189. CYP2D6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
190. BIRC3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
191. CTCF
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
192. EXT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
193. FEV
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
194. HOXD13
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
195. IGH
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
196. JAK1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
197. MEN1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
198. MPL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
199. NRG1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
200. SBDS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
201. SOCS1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
202. U2AF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
203. ATRX
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
204. BCL10
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
205. MYD88
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
206. NPM1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
207. PIM1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
208. PPM1D
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
209. TRIM27
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
210. WAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
211. XPO1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
212. HER1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
213. DEK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
214. EBF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
215. ERCC4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
216. ERG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
217. EWSR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
218. FANCD2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
219. FOXL2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
220. HLF
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
221. HMGA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
222. HOXA9
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
223. NOTCH2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
224. PDGFRA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
225. SDHC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
226. SDHD
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
227. SETBP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
228. TBL1XR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
229. WIF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
230. WFDC2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
231. ARNT
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
232. AXIN1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
233. BCL9
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
234. BRIP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
235. DAXX
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
236. ETV5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
237. FANCC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
238. FOXO3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
239. GPC3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
240. KLF4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
241. LCK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
242. LRIG3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
243. PCSK7
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
244. PTK6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
245. SH2B3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
246. STAT6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
247. TPR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
248. TSHR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
249. AKT2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
250. ASXL1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
251. BCL6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
252. CBL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
253. CCNE1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
254. CDKN2C
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
255. CNBP
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
256. COL2A1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
257. CREB3L1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
258. ELL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
259. ETV4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
260. FLT3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
261. FUBP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
262. HNF1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
263. HOXA11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
264. IDH1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
265. IL6ST
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
266. JAK3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
267. KDM5A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
268. KDM6A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
269. KLK2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
270. MAF
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
271. MAP2K4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
272. MAP3K1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
273. NCOR2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
274. NUMA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
275. NUP214
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
276. PDCD1LG2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
277. PICALM
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
278. PRDM1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
279. PTPN13
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
280. QKI
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
281. SALL4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
282. SPECC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
283. SRSF3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
284. SSX1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
285. TCF3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
286. TET2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
287. TFE3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
288. TFRC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
289. XPC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
290. ZBTB16
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
291. ZNF198
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
292. ZNF331
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
293. Neurokinin
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
294. B2M
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
295. BAP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
296. CASC5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
297. CBFB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
298. CCND2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
299. CD74
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
300. CEBPA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
301. DDX3X
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
302. DDX5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
303. DDX6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
304. DNAJB1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
305. ELF4
    [